Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cns Pharmaceuticals, Inc.

Clinical trials sponsored by Cns Pharmaceuticals, Inc., explained in plain language.

CNS Pharmaceuticals, Inc. CNSP NASDAQ

A clinical-stage biopharmaceutical company developing treatments for brain and central nervous system cancers.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New hope for glioblastoma: experimental drug berubicin faces key trial

Disease control Ongoing

This Phase 2 trial tests an experimental chemotherapy drug called berubicin against a standard drug (lomustine) in 252 adults with recurrent glioblastoma, a severe brain cancer. The goal is to see if berubicin can help patients live longer after standard first-line treatment has …

Phase: PHASE2 • Sponsor: CNS Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC